LIBTAYO (CEMIPLIMAB-RWLC) — FDA Approval BLA761097 (REGENERON PHARMACEUTICALS)
LIBTAYO (CEMIPLIMAB-RWLC) — FDA Approval BLA761097 (REGENERON PHARMACEUTICALS) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: LIBTAYO; Active ingredients: CEMIPLIMAB-RWLC; Application number: BLA761097.
| Brand name | LIBTAYO |
|---|---|
| Active ingredients | CEMIPLIMAB-RWLC |
| Application number | BLA761097 |
| Sponsor | REGENERON PHARMACEUTICALS |
| Dosage form | INJECTABLE |
| Route | INTRAVENOUS |
| Marketing status | Prescription |
| Products in application | 1 |
| First approval date | 20180928 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →